Middle meningeal artery embolization for chronic subdural hematoma
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This study tracks patients who get a procedure called middle meningeal artery embolization (a treatment that blocks blood flow to the lining of the brain to help a chronic subdural hematoma heal). The goal is to see how well it works and how patients recover over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a chronic subdural hematoma confirmed by a CT or MRI scan.
- You are scheduled to have, or have already had, middle meningeal artery embolization (with or without surgery to drain the blood).
- You are able to participate in follow-up exams and phone interviews.
- You have provided written consent to take part.
- You have a moderate level of disability (not completely bedridden) before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a minimally invasive procedure called middle meningeal artery embolization (using tiny particles to block a small artery) to treat chronic subdural hematoma, a condition where blood slowly builds up on the brain's surface. The goal is to help the body reabsorb the blood and prevent the need for repeated surgeries.
This trial tests a procedure that blocks blood flow to the membrane around the brain to treat a chronic subdural hematoma (a slow buildup of blood pressing on the brain). It may help avoid surgery and reduce symptoms like headaches, confusion, or weakness.
This study tests a new way to treat chronic subdural hematomas (a type of bleeding on the brain) by using a very thin tube to seal off a small artery inside the head. This may help the blood clot shrink without needing a traditional surgery.
This trial tests a new technique during surgery for chronic subdural haematoma (bleeding between the brain and skull) where doctors use heat or special tools to seal a blood vessel (the middle meningeal artery) to help prevent the bleed from returning. The goal is to see if this addition to standard surgery is safe and feasible.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This study looks at a procedure called middle meningeal artery embolization, which blocks blood flow to the lining of the brain to help treat a chronic subdural hematoma (a slow bleed on the brain surface). The goal is to see how well this procedure works for adults.
Hear when a new Chronic Subdural Hematomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.